Respiratory function in systemic lupus erythematosus: relation with activity and severity

Abstract

The objective of this study was to examine the relation between respiratory function tests, disease activity and disease severity in ambulatory patients with systemic lupus erythematosus (SLE) who did not present with overt respiratory problems. Lung volumes, maximal expiratory flows at 50% and 25% of vital capacity (MEF₅₀ and MEF₂₅), bronchial threshold to methacholine (PD₁₅FEV ₁), transfer factor CO (KCO) were measured in 24 consecutive SLE outpatients (22 women, age 41 ± 14.8 years) and in 24 healthy controls matched for age and sex. In SLE patients alveolar-arterial oxygen gradient (AaO₂) was also measured. Disease activity was assessed by European Consensus Lupus Activity Measurement (ECLAM) scoring system and disease severity by Lupus Severity of Disease Index. In comparison to controls SLE patients showed a significant decrease of total lung capacity (TLC) (91.7 ± 16.5 vs 102.7 ± 12.9% predicted, P < 0.01), MEF₂₅ (58.4 ± 25.2 vs 73.5 ± 19.5% predicted, P < 0.005), PD₁₅FEV₁ (2164 ± 1122 vs 4230 ± 1014 μg methacholine, P < 0.0001) and KCO (77.1 ± 20.5 vs 96.3 ± 12.4% predicted, P < 0.001). AaO₂ (mean value 13.2 ± 8.4) was abnormally high (>20 mm Hg) in 12 patients. The ECLAM score of activity was inversely related with KCO (r = 0.48, P < 0.02). The severity index was significantly related with FEV₁/VC ratio (r = 0.43, P < 0.05), MEF₅₀ (r = 0.51, P < 0.01), MEF₂₅ (r = 0.40, P < 0.05) and PD₁₅FEV₁ (r = 0.51, P < 0.01). In eight patients, evaluated also after treatment intensification, there was a significant increase in KCO (from 71.8 ± 24.7 to 84.9 ± 22.3% predicted, P < 0.01) along with a decrease in ECLAM score (from 3.0 ± 1.34 to 0.69 ± 0.75, P < 0.01).

The relation between disease activity and KCO suggests a relation between systemic and alveolar inflammation whereas the relation between severity index, airway patency and reactivity indices suggests a cumulative damage to the airways in SLE patients, even in the absence of overt respiratory manifestations.

Keywords

airway hyper-responsiveness respiratory function

Get full access to this article

View all access options for this article.

References

Mulherin D. , Bresnihan B. Systemic lupus erythematosus. Clin Rheum 1993 ; 7: 31-58.

Koerner SK Pulmonary dysfunction in systemic lupus erythematosus: prevalence, classification and correlation with other organ involvement. J Rheum 1980; 7: 187-195.

Holgate ST et al. Respiratory involvement in systemic lupus erythematosus, a clinical and immunologic study. Clin Exp Immunol 1976 ; 24: 385-395.

Segal AM et al. The pulmonary manifestations of systemic lupus erythematosus . Semin Arthritis Rheum 1985; 14: 202-224.

Laitinen O. , Salorinne Y. , Poppius H. Respiratory function in systemic lupus erythematosus, scleroderma and rheumatoid arthritis. Ann Rheum Dis 1973; 32: 531-535.

Andonopoulos AP et al. Pulmonary function of non-smoking patients with systemic lupus erythematosus. Chest 1988 ; 94: 312-315.

Grennan DM et al. Pulmonary involvement in systemic lupus erythematosus. Ann Rheum Dis 1987; 37: 536-539.

Wiedemann HP , Matthay RA Pulmonary manifestations of systemic lupus erythematosus. J Thorac Imaging 1992; 7: 1-18.

Gold WM , Jennings DB Pulmonary function in patients with systemic lupus erythematosus. Am Rev Respir Dis 1966; 93: 556-567.

10.

Huang CT , Lyons HA Comparison of pulmonary function in patients with systemic lupus erythematosus, scleroderma and rheumatoid arthritis. Am Rev Respir Dis 1966; 93: 865-875.

11.

Martens J. et al. Respiratory muscle dysfunction in systemic lupus erythematosus . Chest 1983; 84: 170-175.

12.

Collins RI et al. Cardiopulmonary manifestations of systemic lupus erythematosus . J Rheumatol 1978; 5: 299-306.

13.

Eichacker PQ et al. Serial pulmonary function testing in patients with systemic lupus erythematosus. Chest 1988; 94: 129-132.

14.

Chick TW et al. Pulmonary dysfunction in systemic lupus erythematosus without pulmonary symptoms. J Rheumatol 1976; 3: 262-268.

15.

Gross M. , Esterly JR , Earle RH Pulmonary alterations in systemic lupus erythematosus. Am Rev Respir Dis 1982; 105: 572-577.

16.

Kinney WW , Angelillo VA Bronchiolitis in systemic lupus erythematosus. Chest 1982; 82: 646-649.

17.

Eisenberg H. et al. Diffuse interstitial lung disease in systemic lupus erythematosus. Ann Intern Med 1973; 79: 37-45.

18.

Purnell DC , Baggenstoss AH , Olsen AM Pulmonary lesions in disseminated lupus erythematosus. Ann Intern Med 1955; 42: 619-628.

19.

O'Byrne PM Airway inflammation and airway hyperresponsiveness. Chest 1986; 90: 575-577.

20.

Van Asperen P et al. Bronchial reactivity in cystic fibrosis with normal pulmonary function. Am J Dis Child 1981; 135: 815-819.

21.

Yan K. , Salome CM , Woolcock AJ Prevalence and nature of bronchial hyper-responsiveness in subjects with chronic obstructive pulmonary disease. Am Rev Respir Dis 1985; 132: 25-29.

22.

Tan EM et al. The 1982 revised criteria for the classification of systemic lupus erythematosus (SLE). Arthritis Rheum 1982; 25: 1271-1277.

23.

Ferris BGJr. Epidemiology standardization project. Am Rev Respir Dis 1987; 118: 1-88.

24.

Vitali C. et al and the European Consensus Study Group for Disease Activity in SLE. Disease activity in systemic lupus erythematosus: report of the Consensus Study Group of the European Workshop for Rheumatology Research. Clin Exp Rheumatol 1992; 10: 541-547.

25.

Katz JD et al. A simple severity of disease index for systemic lupus erythematosus . Lupus 1993; 2: 119-123.

26.

American Thoracic Society Executive Committee. Recommended standardized procedures for pulmonary testing. Am Rev Respir Dis 1978; 118: 55-72.

27.

Quanjer PhH (ed.). Standardized lung function testing. Bull Europ Physiopath Respir 1983; 19 (suppl. 5): 45-51.

28.

American Thoracic Society. Single breath carbon monoxide diffusing capacity (transfer factor): recommendation for a standard technique. Am Rev Respir Dis 1987; 136: 1299-1307.

29.

Cotes JE Measurement of the transfer factor (diffusing capacity) for the lung and its subdivisions. In: Cotes JE (ed.) Lung Function. Assessment Application in Medicine, 4th edn. Blackwell Scientific Publication: Oxford, 1979, pp. 230-250.

30.

Chai H. et al. Standardization of bronchial inhalation challenge procedures . J Allergy Clin Immunol 1975; 56: 323-327.

31.

Hellmann DB et al. Dyspnea in ambulatory patients with SLE: prevalence, severity and correlation with incremental exercise testing. J Rheumatol 1995; 22: 455-461.

32.

Fulmer JO , Roberts WC Commentary: small airways and interstitial pulmonary disease. Chest 1980; 77: 470-472.

33.

Groen H. et al. Bronchoalveolar lavage cell analysis and lung function impairment in patients with systemic lupus erythematosus. Clin Exp Immunol 1993; 94: 127-133.

34.

Moreno RH , Pare PD , Hogg JC Mechanics of airway narrowing. Am Rev Respir Dis 1986; 136: 1171-1180.

35.

Eiser AR , Shanies HM Treatment of lupus interstitial lung disease with intravenous cyclophosphamide . Arthritis Rheum 1994; 37: 428-431.